Confirm candidacy
Confirm whether complete cytoreductive surgery is achievable in your case.
Specialized Unit
Peritoneal Carcinomatosis of Colorectal Origin
At Quenet-Torrent Institute, we treat peritoneal carcinomatosis of colorectal origin with complete cytoreductive surgery, with or without HIPEC, in carefully selected patients and always within a multidisciplinary environment.
CONTACT SPECIALIST
Our team's track record
World leaders in abdominal oncological surgery
The Quenet Torrent Institute team brings decades of international experience in highly complex oncological surgery, with results published in leading scientific journals and recognition from European surgical oncology societies.
+20,000
Oncological surgeries performed
+500
Cytoreductive surgery + HIPEC procedures
30+
Years of international experience
Top
European reference centre in carcinomatosis
Clinical summary
Peritoneal carcinomatosis of colorectal origin is treated with complete cytoreductive surgery following the PRODIGE-7 trial criteria (Quenet F et al., JCO 2021). At Quenet-Torrent Institute (Teknon Barcelona · Memorial Publio Cordón Madrid), Dr. François Quenet (principal investigator of the trial), Dr. Torrent and Prof. González Bayón apply PCI-based selection and a multidisciplinary approach.
What is colorectal peritoneal carcinomatosis?
Colorectal peritoneal carcinomatosis occurs when cancer cells from the colon or rectum spread to the peritoneal surface. It is diagnosed in approximately 10-15% of colorectal cancer patients, either synchronously at initial diagnosis or as a recurrence after treatment.
Historically considered a terminal condition, today we know that complete cytoreductive surgery (CC0), sometimes combined with HIPEC, can achieve 5-year survival of 30-40% in properly selected patients — results significantly superior to systemic chemotherapy alone.
The key factor is strict patient selection based on peritoneal disease extent (PCI), functional status, tumor biology, and response to systemic treatments.
Why request a second opinion for colorectal carcinomatosis?
Requesting a second opinion can reveal treatment options not initially considered.
Evaluate the PRODIGE 7 context
Understand whether HIPEC adds benefit in your specific situation based on current evidence.
PCI assessment
Obtain an expert evaluation of your peritoneal disease index and resectability.
Clinical trials
Consider participation in clinical trials with innovative perioperative strategies.
A specialized evaluation can change the prognosis in selected patients.
How do we treat colorectal carcinomatosis?
Treatment is based on complete cytoreduction combined with systemic and locoregional strategies tailored to each patient.
Neoadjuvant chemotherapy
Systemic treatment to evaluate tumor biology and select patients with chemosensitive disease.
Complete cytoreductive surgery (CC0)
Removal of all visible peritoneal disease — the most critical prognostic factor.
HIPEC (selected cases)
Hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin C in individualized cases.
Adjuvant chemotherapy
Postoperative systemic treatment according to molecular profile and risk stratification.
Patient selection is strict and based on multiple clinical, radiological, and pathological factors.
Our Technology
Technology for treating colorectal carcinomatosis
Precise diagnostic and surgical technology ensures the best possible patient selection and outcomes.
Staging laparoscopy
Direct PCI evaluation and resectability assessment before committing to open surgery.
PET-CT
Detection of extra-abdominal disease that would contraindicate surgery.
Automated HIPEC equipment
Precise thermal and flow control during perfusion when indicated.
Multidisciplinary tumor board
All cases discussed in a specialized committee with surgeons, oncologists, and radiologists.
WHY CHOOSE US?
Experience in colorectal carcinomatosis
Quenet-Torrent Institute offers a comprehensive approach, with teams specialized in advanced peritoneal disease.
Experience in Complex Cases
We specialize in treating advanced and metastatic cancer, using innovative techniques that other teams do not offer.
Comprehensive Multidisciplinary Approach
We form a team around you with surgeons, oncologists, radiologists, nutritionists, and psychologists, all working together for your cure.
Research and Innovation
We stay up to date with the latest scientific advances, allowing us to apply innovative treatments with better results.
State-of-the-Art Technology
We have facilities equipped with the most current medical technology, allowing us to perform high-precision procedures with less impact on the body.
Personalized and Close Care
We care about each patient as a person. We listen, support, and guide every step of the way.
Our Team
Colorectal carcinomatosis specialists
Every physician at Quenet-Torrent Institute is a recognized expert in their field, committed to each patient's well-being.
Dr. François Quenet
Oncological Surgeon
View doctor"Internationally renowned surgeon, expert in gastrointestinal and hepatobiliary tumors. Recognized for his precision in highly difficult surgeries."
Dr. Juan José Torrent
Oncological Surgeon
View doctor"Specialist in gynecological tumors and peritoneal carcinomatosis. A reference in complex and personalized oncological surgery."
Where to treat
Where to treat colorectal peritoneal carcinomatosis?
The Quenet-Torrent team consults and operates in two leading private hospitals in Spain, and welcomes international patients with prior remote case assessment.
Barcelona
Centro Médico Teknon
Carrer de Vilana, 12 · 08022 Barcelona, Spain
- Consultations with the Quenet-Torrent team
- High-complexity surgical theatre and HIPEC
- Reference private hospital in Catalonia
Madrid
Memorial Publio Cordón Hospital
Paseo de la Casa de Campo, 5 · 28223 Pozuelo de Alarcón, Madrid, Spain
- Surgical oncology unit of the Quenet-Torrent team
- Cytoreductive surgery, HIPEC, PIPAC and robotics
- High-tech private hospital (2026)
International
Patients from around the world
We receive patients with colorectal peritoneal carcinomatosis referred from Europe, Latin America and the Middle East.
- Remote case assessment by our committee
- Travel and stay coordination in Spain
- Care in Spanish, English and French
Frequently asked questions about colorectal carcinomatosis
Answers to the most common questions about diagnosis, treatment, and prognosis.
Are all patients with colorectal carcinomatosis candidates for surgery?
No. Strict selection is required: limited PCI, good functional status (ECOG 0-1), possibility of complete cytoreduction, and absence of unresectable extra-peritoneal.
What is the significance of the PRODIGE 7 study?
PRODIGE 7 demonstrated that complete cytoreductive surgery is the most important factor for survival. HIPEC adds benefit in selected cases but does not replace quality.
When is HIPEC indicated in colorectal carcinomatosis?
The indication for HIPEC is individualized. It may benefit patients with complete cytoreduction, especially those with moderate PCI and no contraindications to.
What is the Peritoneal Carcinomatosis Index (PCI)?
The PCI quantifies the extent of peritoneal disease (0-39 points). A low PCI (<15-20) is associated with better prognosis and higher probability of compl.
What survival can be expected after surgery?
With complete cytoreduction (CC0), 5-year survival ranges from 30-40% in selected series — significantly better than systemic chemotherapy alone Outcomes depend on histology, PCI score, and completeness of cytoreduction.
Where can I receive this treatment safely?
In specialized centers with experience in peritoneal surface malignancies, like Quenet-Torrent Institute Chemotherapy complements surgery to optimise overall oncological control.
Verified reviews
See on Google
★★★★★
What our patients say
L
4 weeks ago
★★★★★
Wonderful surgical team, among the best out there. Dr. Torrent (expert in peritoneal carcinomatosis) is an exceptional surgeon and an even better person. His coordinator is super kind, fast and efficient. The human treatment is great and the results are too. This is of vital importance for cancer patients.
K
5 months ago
★★★★★
In the public healthcare system they gave my father a maximum of one year to live. They only offered him chemo and no hope, said it was impossible, that nothing could be done. He had several tumors inside the peritoneal sac with metastases. A year and a half later he is clean, completely cured. His latest PET scan came back clean. We are very happy. Thanks to Dr. Torrent and his team. THANK YOU.
M
A year ago
★★★★★
Excellent professionals, especially Dr. Torrent, attentive at all times to the patient (my wife), operated for peritoneal pseudomyxoma. They helped us with all our needs since we came from outside Barcelona. Thank you Elisabeth. We are very grateful to Quenet Torrent Institute, thank you for everything.
P
2 years ago
★★★★★
I am a 63-year-old patient. They detected adrenal gland cancer and told me there was nothing to be done. I sought a second opinion and they told me about the Quenet Torrent team, specialists in complex operations. Dr. Torrent, from the first moment, told me they could operate. They operated and removed a large tumor mass. I spent a week in the ICU and a month on the ward. Every day he came morning and evening, no matter Saturday or Sunday. Never throw in the towel. I am happy to have found these professionals who gave me my life back. Thank you.
I
3 years ago
★★★★★
Many thanks for your attention. Dr. Torrent always attentive, involved and decisive. The reception staff very pleasant and always offering the best option. 100% RECOMMENDED. THANK YOU.
M
5 years ago
★★★★★
Dr. Torrent helped me make the best decision at a difficult moment. I think he is a great professional and a person capable of accompanying you and putting himself in another's shoes. Thank you for everything.
F
6 years ago
★★★★★
I have peritoneal carcinomatosis. Sending my diagnosis to every center, practically all agreed on palliative chemo with little survival time since I had very aggressive cell types. Until we reached Dr. Quenet, Dr. Torrent and their team. I can only confirm what their CV announces: they are far ahead of the rest. They saved my life — at surgery the harmful cells everyone diagnosed (and used to refuse to operate) were not there. This intervention has become the best investment of my life.
Where to treat peritoneal carcinomatosis of colorectal origin?
We operate in two private hospitals of reference in Spain. The same medical team treats you in Madrid and Barcelona, with the same surgical and oncological standards.
Madrid
Memorial Publio Cordón Hospital
Private hospital in Pozuelo de Alarcón with a multidisciplinary team specialised in digestive surgical oncology and cutting-edge surgical technology.
View hospital
Barcelona
Centro Médico Teknon
Leading private hospital in Barcelona where the team carries out its high-complexity surgical oncology activity.
Page coming soon
Real cases
Patient testimonies and surgery explanations
Real testimonies from patients treated by our team in high-complexity surgical oncology.
Debra's case
66-year-old English woman with advanced ovarian cancer and peritoneal metastases. Treated with cytoreduction + HIPEC, she is now disease-free.
Read the full caseRosario (Charo)'s case
73-year-old patient with advanced cancer treated with chemotherapy and high-complexity surgical oncology. Excellent survival and quality of life.
Read the full caseLaura's case
Rare abdominal tumor treated with complex cytoreductive surgery plus HIPEC and systemic chemotherapy. Disease-free after almost 2 years.
Read the full caseSantiago's case
Diagnosed with widespread peritoneal carcinomatosis and considered inoperable. After complete cytoreduction with HIPEC, today his is a story of hope and survival.
Read the full case
Verified reviews
See on Google
★★★★★
What our patients say
L
4 weeks ago
★★★★★
Wonderful surgical team, among the best out there. Dr. Torrent (expert in peritoneal carcinomatosis) is an exceptional surgeon and an even better person. His coordinator is super kind, fast and efficient. The human treatment is great and the results are too. This is of vital importance for cancer patients.
K
5 months ago
★★★★★
In the public healthcare system they gave my father a maximum of one year to live. They only offered him chemo and no hope, said it was impossible, that nothing could be done. He had several tumors inside the peritoneal sac with metastases. A year and a half later he is clean, completely cured. His latest PET scan came back clean. We are very happy. Thanks to Dr. Torrent and his team. THANK YOU.
M
A year ago
★★★★★
Excellent professionals, especially Dr. Torrent, attentive at all times to the patient (my wife), operated for peritoneal pseudomyxoma. They helped us with all our needs since we came from outside Barcelona. Thank you Elisabeth. We are very grateful to Quenet Torrent Institute, thank you for everything.
P
2 years ago
★★★★★
I am a 63-year-old patient. They detected adrenal gland cancer and told me there was nothing to be done. I sought a second opinion and they told me about the Quenet Torrent team, specialists in complex operations. Dr. Torrent, from the first moment, told me they could operate. They operated and removed a large tumor mass. I spent a week in the ICU and a month on the ward. Every day he came morning and evening, no matter Saturday or Sunday. Never throw in the towel. I am happy to have found these professionals who gave me my life back. Thank you.
I
3 years ago
★★★★★
Many thanks for your attention. Dr. Torrent always attentive, involved and decisive. The reception staff very pleasant and always offering the best option. 100% RECOMMENDED. THANK YOU.
M
5 years ago
★★★★★
Dr. Torrent helped me make the best decision at a difficult moment. I think he is a great professional and a person capable of accompanying you and putting himself in another's shoes. Thank you for everything.
F
6 years ago
★★★★★
I have peritoneal carcinomatosis. Sending my diagnosis to every center, practically all agreed on palliative chemo with little survival time since I had very aggressive cell types. Until we reached Dr. Quenet, Dr. Torrent and their team. I can only confirm what their CV announces: they are far ahead of the rest. They saved my life — at surgery the harmful cells everyone diagnosed (and used to refuse to operate) were not there. This intervention has become the best investment of my life.
Easy Contact
Need to speak with a specialist?
Complete the form and schedule your appointment to speak directly with the surgeon.